{"id":1081989,"title":"DSEN Abstract: How does real world use of insulin glargine compare to NPH insulin in terms of effectiveness and safety for the management of type 1 diabetes mellitus (T1DM)? - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-03-20","captureTimestamp":"2026-03-20T21:25:50.545000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/51607.html?wbdisable=true","snippet":"DSEN Abstract How does real world use of insulin glargine compare to NPH insulin in terms of effectiveness and safety for the management of type 1 diabetes mellitus (T1DM)? This research was funded by the Drug Safety and Effectiveness Network (DSEN) and conducted by the following…","rawSnapshotUrl":"/api/snapshots/raw/1081989","browseUrl":"https://replay.healtharchive.ca/job-8/20260320212550/https://cihr-irsc.gc.ca/e/51607.html?wbdisable=true#ha_snapshot=1081989","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}